The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Second-Trimester Ultrasound to Detect Fetuses With Down Syndrome: A Meta-analysis
Abstract
CONTEXT: Second-trimester prenatal ultrasound is widely used in an attempt to detect Down syndrome in fetuses, but the accuracy of this method is unknown. OBJECTIVE: To determine the accuracy of second-trimester ultrasound in detecting Down syndrome in fetuses. DATA SOURCES: English-language articles published between 1980 and February 1999 identified through MEDLINE and manual searches. STUDY SELECTION: Studies were included if they recorded second-trimester findings of ultrasonographic markers, chromosomal abnormalities, and clinical outcomes for a well-described sample of women. A total of 56 articles describing 1930 fetuses with Down syndrome and 130 365 unaffected fetuses were included. DATA EXTRACTION: Articles were independently reviewed, selected, and abstracted by 2 reviewers. Discrepancies in data abstraction were resolved by consensus with a third reviewer. Overall estimates of sensitivity, specificity, and positive and negative likelihood ratios were calculated for the following markers: choroid plexus cyst, thickened nuchal fold, echogenic intracardiac focus, echogenic bowel, renal pyelectasis, and humeral and femoral shortening. Results were stratified by whether markers were identified in isolation or in conjunction with fetal structural malformations. DATA SYNTHESIS: When ultrasonographic markers were observed without associated fetal structural malformations, sensitivity for each was low (range, 1%-16%), and most fetuses with such markers had normal outcomes. A thickened nuchal fold was the most accurate marker for discriminating between unaffected and affected fetuses and was associated with an approximately 17-fold increased risk of Down syndrome. If a thickened nuchal fold is used to screen for Down syndrome, 15 893 average-risk women or 6818 high-risk women would need to be screened for each case of Down syndrome identified. For each of the other 6 markers, when observed without associated structural malformations, the marker had marginal impact on the risk of Down syndrome. Because the markers were detected in only a small number of affected fetuses, the likelihood of Down syndrome did not decrease substantially after normal examination findings (none of the negative likelihood ratios were significant). CONCLUSIONS: A thickened nuchal fold in the second trimester may be useful in distinguishing unaffected fetuses from those with Down syndrome, but the overall sensitivity of this finding is too low for it to be a practical screening test for Down syndrome. When observed without associated structural malformations, the remaining ultrasonographic markers could not discriminate well between unaffected fetuses and those with Down syndrome. Using these markers as a basis for deciding to offer amniocentesis will result in more fetal losses than cases of Down syndrome detected, and will lead to a decrease in the prenatal detection of fetuses with Down syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Smith's recognizable patterns of human malformation
Jones, K. L., Jones, M. C., & Campo, M. D. (1997) · Cited by 1,916
Empirical evidence of design-related bias in studies of diagnostic tests.
Lijmer, J. G. (1999) · JAMA · doi:10.1001/jama.282.11.1061 · Cited by 1,861
Systematic reviews of evaluations of diagnostic and screening tests
Deeks, J. J. (2001) · BMJ · doi:10.1136/bmj.323.7305.157 · Cited by 1,340
Self-citationMaternal serum screening for Down's syndrome in early pregnancy.
Wald, N. J., Cuckle, H. S., Densem, J. W., Nanchahal, K., Royston, P., Chard, T., Haddow, J. E., Knight, G. J., Palomaki, G. E., & Canick, J. A. (1988) · BMJ · doi:10.1136/bmj.297.6653.883 · Cited by 966
RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMEN
Tabor, A., Madsen, M., Obel, E., Philip, J., Bang, J., & Gaard-Pedersen, B. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91218-3 · Cited by 869
Endovaginal Ultrasound to Exclude Endometrial Cancer and Other Endometrial Abnormalities
Smith-Bindman, R., Kerlikowske, K., Feldstein, V. A., Subak, L., Scheidler, J., Segal, M., Brand, R., & Grady, D. (1998) · JAMA · doi:10.1001/jama.280.17.1510 · Cited by 736
Self-citationWald, N. J., Watt, H. C., & Hackshaw, A. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410701 · Cited by 530
Meta-analytic methods for diagnostic test accuracy
Irwig, L., Macaskill, P., Glasziou, P., & Fahey, M. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00099-c · Cited by 467
Prenatal Screening for Down's Syndrome with Use of Maternal Serum Markers
Haddow, J. E., Palomaki, G. E., Knight, G. J., Williams, J., Pulkkinen, A., Canick, J. A., Saller, D. N., & Bowers, G. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270902 · Cited by 454
Antenatal Screening for Down's Syndrome
Wald, N. J., Kennard, A., Hackshaw, A., & McGuire, A. (1997) · Journal of Medical Screening · doi:10.1177/096914139700400402 · Cited by 406
Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis
(1998) · The Lancet · doi:10.1016/s0140-6736(97)12346-7 · Cited by 318
Sonographic Identification of Second-Trimester Fetuses with Down's Syndrome
Benacerraf, B. R., Gelman, R., & Frigoletto, F. D. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172203 · Cited by 317
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome
CANICK, J. A., KNIGHT, G. J., PALOMAK1, G. E., HADDOW, J. E., CUCKLE, H. S., & WALD, N. J. (1988) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1988.tb06601.x · Cited by 306
Chitty, L. S., Hunt, G. H., Moore, J., & Lobb, M. O. (1991) · BMJ · doi:10.1136/bmj.303.6811.1165 · Cited by 292
Chromosomal abnormality rates at amniocentesis and in live-born infants
Hook, E. B. (1983) · JAMA · doi:10.1001/jama.249.15.2034 · Cited by 289
Estimates of the economic costs of birth defects.
Waitzman, N. J., Romano, P. S., & Scheffler, R. M. (1994) · PubMed · Cited by 210
Sonographic scoring index for prenatal detection of chromosomal abnormalities
Benacerraf, B. R., Neuberg, D. S., Bromley, B., et al. (1992) · Journal of Ultrasound in Medicine · doi:10.7863/jum.1992.11.9.449 · Cited by 173
Prenatal sonographic findings of Down syndrome: Review of 94 cases
Nyberg, D., Resta, R., Luthy, D., Hickok, D., Mahoney, B., & Hirsch, J. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90112-i · Cited by 162
6-year experience of prenatal diagnosis in an unselected population in Oxford, UK
Boyd, P., Chamberlain, P., & Hicks, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03202-4 · Cited by 160
A sonographic screening method for Down syndrome
Lockwood, C. J., Benacerraf, B. R., Krinsky, A. H., Blakemore, K. J., Belanger, K. D., Mahoney, M., & Hobbins, J. C. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(87)80059-5 · Cited by 150
Women's decision-making in prenatal screening
Santalahti, P., Hemminki, E., Latikka, A., & Ryynänen, M. (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(97)10038-7 · Cited by 110
Ultrasound screening for fetal abnormalities
Chitty, L. S. (1995) · Prenatal Diagnosis · doi:10.1002/pd.1970151306 · Cited by 106
Evaluation of prenatal diagnosis of congenital heart disease
Stoll, C. G., Alembik, Y., Dott, B., Roth, P. M., & de Geeter, B. (1993) · Prenatal Diagnosis · doi:10.1002/pd.1970130606 · Cited by 101
Winter, T. C., Uhrich, S. B., Souter, V. L., & Nyberg, D. A. (2000) · Radiology · doi:10.1148/radiology.215.3.r00ma36775 · Cited by 48
Screening for fetal anomalies by ultrasound at 14 and 21 weeks
D'Ottauio, G., Meir, Y. J., Rustico, M. A., Pecile, V., Fischer-Tamaro, L., Conoscenti, G., Natale, R., & Mandruzzato, G. P. (1997) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1997.10060375.x · Cited by 47
Dallaire, L., Lortie, G., Rochers, M. D., Clermont, R., & Vachon, C. (1995) · Prenatal Diagnosis · doi:10.1002/pd.1970150308 · Cited by 45
Cited by
Roizen, N. J., & Patterson, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12987-x · Cited by 1,331
Screening for fetal aneuploidies at 11 to 13 weeks
Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2637 · Cited by 642
Evidence of bias and variation in diagnostic accuracy studies
Rutjes, A. W. S., Reitsma, J. B., Di Nisio, M., Smidt, N., van Rijn, J. C., & Bossuyt, P. M. M. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050090 · Cited by 611
Alldred, S. K., Takwoingi, Y., Guo, B., Pennant, M., Deeks, J. J., Neilson, J. P., & Alfirevic, Z. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012599 · Cited by 529
Self-citationApproaches to heterogeneity in meta‐analysis
Petitti, D. B. (2001) · Statistics in Medicine · doi:10.1002/sim.1091 · Cited by 464
Metadata
- Authors
- Smith-Bindman, R., Hosmer, W., Feldstein, V. A., Deeks, J. J., & Goldberg, J. D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-02-28
- Volume
- 285
- Issue
- 8
- Pages
- 1044
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2030693174
- Cited by
- 306
- References
- 27
- FWCI
- 16.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.